Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Aug 01, 2005 (Vol. 25, No. 14)

TOXMAP

URL:toxmap.nlm.nih.gov/toxmap/main/index.jsp
  • Easy access to information
  • Not comprehensive
No sooner did I write the column above complaining about the EPA’s lack of online access for information and suggesting that they model the NIH’s sites than I found the NIH’s TOXMAP site, which partially implements my suggestions. TOXMAP provides a “top-down” approach to toxic chemicals in the environment. The opening page provides a map of the U.S. on which users click to learn of toxic chemicals at that desired site. Sites can also be located by chemical name or city/state/zip. Sources of information about the chemicals are reports filed by local companies. I was aghast to discover how many pounds of chemicals were being released by relatively clean industries in my area. While TOXMAP is not a one-stop shop for information about chemicals, it does provide easy access to information about chemicals in any desired area in a much better way than EPA’s site above.
  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good


*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »